hmmm...well look at that ....it looks so familar ...well it's very close to the current website don't it...
Earnest Dr. Roberge has been trying to market this stuff for over 10 years without much success.
Anyone see a SymPath® kit in their local drug store since 2000 ?
Dr. Roberge filed these interesting comments in her SEC filing:
RESEARCH AND DEVELOPMENT
The Company's research and development efforts are devoted to the development of diagnostic kits, therapeutics and clinical laboratory services. Total research and development expense for 1999 and 1998 was $1,149,885 and $1,143,741, respectively. The research and development plans for fiscal year 2000 call for approximately $2.5 million in research and development costs. The Company plans on using SymPath-TM- revenues to fund this increase
PATENTS AND PROPRIETARY INFORMATION
There has been, and the Company believes that there may be in the future, significant litigation in the industry regarding patent and other intellectual property rights and that, if the Company becomes involved in such litigation, it could consume substantial resources. Significant legal issues remain as to the extent to which patent protection may be afforded in the field of biotechnology in the United States, Canada and other countries, and the scope of any such protection has not yet been broadly tested. The Company, therefore, also relies upon trade secrets, know-how, and continuing technological advancement to develop and maintain its competitive position. Disclosure and use of the Company's know-how is generally controlled under agreements with the parties involved. In addition, the Company has confidentiality agreements with its key employees, consultants, officers and directors. There can be no assurance, however, that all confidentiality agreements will be honored, that others will not independently develop equivalent technology, that disputes will not arise as to the ownership of intellectual property, or that disclosure of the Company's trade secrets will not occur. Furthermore, there can be no assurance that others have not obtained or will not obtain patent protection that will exclude the Company from using its trade secrets and confidential information. To the extent that consultants or research collaborators use intellectual property owned by others in their work with the Company, disputes may also arise as to the rights to related or resulting know-how or inventions.
Moreover, then Neuro-Biotech was involved in a rather nasty legal dispute involving it's shares, and one of the litigants was ...wait for it a BAHAMIAN company:
News 
Market Data 
Discover 
